Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Stahel

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|April 5, 2015
Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgeryLukas Frischknecht, Mayura Meerang, Alex Soltermann, et al.
Frontiers in Oncology|October 17, 2019
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality TherapyChristina Schröder, Isabelle Opitz, Matthias Guckenberger, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 24, 2006
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesotheliomaIsabelle Opitz, Peter Kestenholz, Didier Lardinois, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 18, 2019
ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment TestNicholas Pavlidis, Fedro Peccatori, Matti Aapro, et al.
BMC Pulmonary Medicine|August 14, 2014
Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort studyDaniel Franzen, Matthias Diebold, Alex Soltermann, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 6, 2008
PTEN expression is a strong predictor of survival in mesothelioma patientsIsabelle Opitz, Alex Soltermann, Martin Abaecherli, et al.
BMC Cancer|December 25, 2012
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)Ulf Petrausch, Petra C Schuberth, Christian Hagedorn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 19, 2020
Clinical Case Presentation and Discussion During ESO-ESMO Masterclass: a 10-Year Interactive Educational ExperienceNicholas Pavlidis, Fedro A Peccatori, Matti Aapro, et al.
Frontiers in Oncology|March 13, 2018
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor ProgressionKathrin Oehl, Jelena Kresoja-Rakic, Isabelle Opitz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 22, 2015
Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesotheliomaArthur Kostron, Martina Friess, Ornella Crameri, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Thoracic and Cardiovascular Surgery|April 5, 2015
Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgeryLukas Frischknecht, Mayura Meerang, Alex Soltermann, et al.
Frontiers in Oncology|October 17, 2019
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality TherapyChristina Schröder, Isabelle Opitz, Matthias Guckenberger, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 24, 2006
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesotheliomaIsabelle Opitz, Peter Kestenholz, Didier Lardinois, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 18, 2019
ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment TestNicholas Pavlidis, Fedro Peccatori, Matti Aapro, et al.
BMC Pulmonary Medicine|August 14, 2014
Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort studyDaniel Franzen, Matthias Diebold, Alex Soltermann, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 6, 2008
PTEN expression is a strong predictor of survival in mesothelioma patientsIsabelle Opitz, Alex Soltermann, Martin Abaecherli, et al.
BMC Cancer|December 25, 2012
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)Ulf Petrausch, Petra C Schuberth, Christian Hagedorn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 19, 2020
Clinical Case Presentation and Discussion During ESO-ESMO Masterclass: a 10-Year Interactive Educational ExperienceNicholas Pavlidis, Fedro A Peccatori, Matti Aapro, et al.
Frontiers in Oncology|March 13, 2018
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor ProgressionKathrin Oehl, Jelena Kresoja-Rakic, Isabelle Opitz, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 22, 2015
Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesotheliomaArthur Kostron, Martina Friess, Ornella Crameri, et al.
Pageof 9